PATENT CLAIM ANALYSIS

Application Number: 16224004
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["514", "100000"]

Abstract:
In an aspect, the invention relates to compositions and methods for permeabilizing membranes of cells. In an aspect, the invention relates to compositions and methods for killing cells. In an aspect, the invention relates to compositions and methods of permeabilizing the membranes of cancer cells or microbial cells.

Claim (Index 1):
A method for treating cancer in a subject, comprising administering to the subject a therapeutically effective amount of a composition comprising a C-terminal B cell lymphoma-2 (Bcl-2)-associated X protein (Bax) peptide (CT20p peptide) and a pharmaceutically acceptable carrier, wherein the CT20p peptide consists of the amino acid sequence of SEQ ID NO: 1 or comprises the amino acid sequence of SEQ ID NO: 2, 3, or 4.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 98.0
- Lexical Diversity: 2.57143
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14717884', '14240801', '13478831', '11695321', '13393394']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7427436905112297
- 35 USC 102 Novelty (BERT): 0.5429229486350938
- Combined Prediction Score: 0.7227616163236161
- Mean Citation Score: 272.88016000000005
- Max Citation Score: 386.19415
- Similarity Product: 334.0648951605022

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test